ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,464.62
0.00%
US Tech 100
19,143.20
-0.33%
다우존스 지수
39,150.33
0.00%
Bitcoin
61,120.47
-3.23%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) 뉴스

PRTC PureTech Health PLC

28.3901
0.00 (0.00%)
시간외 단일가
최종 업데이트: 21:31:13
15분 지연
기업명 주식 심볼 시장 주식 타입
PureTech Health PLC PRTC 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 28.3901 21:31:13
개장가 저가 고가 종가 전일 종가
28.3901
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/06/202415:00BWPureTech Health: Results of the Tender Offer
20/06/202415:00BWPureTech Announces Change of Board Role
18/06/202420:05BWPureTech Founded Entity Seaport Therapeutics Appoints..
14/06/202405:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/06/202402:15BWPureTech Health: Results of Annual General Meeting
07/06/202405:39EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
07/06/202405:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/06/202401:38BWPureTech Health: Result of General Meeting
05/06/202405:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/06/202420:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
30/05/202421:05EDGAR2Form SC 13D/A - General statement of acquisition of..
30/05/202405:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/05/202421:09BWPureTech Founded Entity Akili Interactive and Virtual..
23/05/202420:00BWPureTech to Present at the Jefferies Global Healthcare..
21/05/202420:05BWPureTech Founded Entity Vedanta Biosciences Enrolls First..
21/05/202405:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/05/202420:03EDGAR2Form SC TO-I - Tender offer statement by Issuer
20/05/202415:00BWPureTech Health: Launch of Proposed $100 Million Tender..
09/05/202420:05BWPureTech Founded Entity Seaport Therapeutics Presents Data..
07/05/202420:05BWPureTech Founded Entity Seaport Therapeutics Adds Industry..
25/04/202418:22BWPureTech Announces Annual Results for Year Ended December..
18/04/202415:00BWPureTech Health: Notice of Results
16/04/202420:00BWPureTech Announces Completion of Enrollment in Phase 2b..
11/04/202420:00BWPureTech Receives FDA Fast Track Designation for LYT-200 in..
09/04/202415:00BWPureTech Launches Seaport Therapeutics with $100 Million..
19/03/202416:00BWPureTech Proposes $100 Million Capital Return
18/03/202422:52BWBristol Myers Squibb Completes Acquisition of PureTech's..
13/03/202420:00BWPureTech Receives Orphan Drug Designation for LYT-200 in..
27/02/202421:00BWPureTech to Present at Two Upcoming Investor Conferences
27/02/202416:00BWPureTech Founded Entity Akili Announces Positive Results..
05/01/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/01/202421:00BWPureTech to Present at 42nd Annual J.P. Morgan Healthcare..
22/12/202323:13BWPureTech Founded Entity Karuna Therapeutics to be Acquired..
20/12/202316:00BWPureTech Year End Update and Outlook for 2024
07/12/202320:00BWPureTech Presents Data from Phase 1 Trial of LYT-200..
30/11/202300:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
17/11/202316:00BWPureTech Founded Entity Karuna Therapeutics Announces..
14/11/202316:00BWPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary..
03/11/202305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/10/202315:00BWPureTech to Present at Two Upcoming Investor Conferences
11/10/202320:00BWPureTech Presents Data from LYT-100 (Deupirfenidone) Trial..
04/10/202320:05BWPureTech Founded Entity Vedanta Biosciences Announces First..
28/09/202320:38BWKarXT, invented at PureTech, submitted for FDA Approval in..
27/09/202315:05BWPureTech Announces the Appointment of Robert Lyne as Chief..
07/09/202305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/08/202319:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/08/202315:00BWPureTech Health plc – Half-Year Report
22/08/202315:00BWPureTech Health: Notice of Half-Yearly Results
03/08/202305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/08/202320:00BWPureTech Awarded up to $11.4 Million from U.S. Department of..

최근 히스토리

NASDAQ
PRTC
PureTech Health
LSE
QH09
Morg.st.b.v 26
EU
CAAB
Credit Agricole Assuranc...
TG
A28242
CPT BV
BOV
SHOW3M
TIME FOR FUN ON
TG
A3LEBC
General Motors
BIT
IBCX
Exchange Traded
COIN
DAPSUSD
DAPS Coin
BIT
UB8KNQ
Unicredit Bank
BIT
FVTSRB
Vontobel
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유